Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sacha Rothschield"'
Autor:
Alfred Zippelius, Petra Herzig, Heinz Läubli, Gieri Cathomas, Christian Klein, Marta Trüb, Franziska Uhlenbrock, Christina Claus, Martin Thelen, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara-Koller, Daniela Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D Mertz, Robert Rosenberg, Viola Heinzelmann-Schwarz, Mark Wiese, Didier Lardinois, Pablo Umana, Abhishek S Kashyap
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The costimulatory receptor 4-1BB (CD137, TNFRSF9) plays an important role in sustaining effective T cell immune responses and is investigated as target for cancer therapy. Systemic 4-1BB directed therapies elicit toxicity or low efficacy,
Externí odkaz:
https://doaj.org/article/812e0e185e314e829d4e8fe6aa67b3da
Autor:
Daniela S. Thommen, Didier Lardinois, Pablo Umana, Mark Wiese, Vaios Karanikas, Kirsten D. Mertz, Martin Thelen, Christina Claus, Maria Amann, Viola Heinzelmann-Schwarz, Alfred Zippelius, Marina Bacac, Marta Trüb, Heinz Läubli, Gieri Cathomas, Christian Klein, Rosemarie Albrecht, Franziska Uhlenbrock, Petra Herzig, Abhishek S. Kashyap, Claudia Ferrara-Koller, Spasenija Savic Prince, Sacha Rothschield, Robert Rosenberg
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundThe costimulatory receptor 4-1BB (CD137, TNFRSF9) plays an important role in sustaining effective T cell immune responses and is investigated as target for cancer therapy. Systemic 4-1BB directed therapies elicit toxicity or low efficacy, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e32b3fafb678a789d0f91c1b4003248f
http://europepmc.org/articles/PMC7333869
http://europepmc.org/articles/PMC7333869